Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
6.60
+1.11 (20.22%)
At close: Aug 7, 2025, 4:00 PM
6.62
+0.02 (0.30%)
Pre-market: Aug 8, 2025, 8:25 AM EDT

Xeris Biopharma Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2020
Net Income
--54.84-62.26-94.66-122.73-91.14
Upgrade
Depreciation & Amortization
-12.6313.1612.671.881.47
Upgrade
Other Amortization
-3.012.211.560.960.98
Upgrade
Loss (Gain) From Sale of Assets
-0.090.320.24--
Upgrade
Loss (Gain) From Sale of Investments
--0.75-1.260.180.410.08
Upgrade
Stock-Based Compensation
-18.3610.7212.1611.388.27
Upgrade
Other Operating Activities
--6.66-3.610.110.72.58
Upgrade
Change in Accounts Receivable
--1.22-8.37-13.37-6.24-2.18
Upgrade
Change in Inventory
--8.78-14.8-7.47-7.42-5.14
Upgrade
Change in Accounts Payable
--9.616.96-4.325.53-2.49
Upgrade
Change in Other Net Operating Assets
-10.799.92-9.9919.987.01
Upgrade
Operating Cash Flow
--36.98-47.02-102.89-95.54-80.56
Upgrade
Capital Expenditures
--0.87-2.26-0.52-1.09-0.38
Upgrade
Cash Acquisitions
----38.47-
Upgrade
Investment in Securities
-5.75-3.7434.9960.58-27.03
Upgrade
Investing Cash Flow
-4.88-634.4697.96-27.41
Upgrade
Long-Term Debt Issued
-50-146.21-94.84
Upgrade
Long-Term Debt Repaid
----43.5--25.09
Upgrade
Net Debt Issued (Repaid)
-50-102.72-69.75
Upgrade
Issuance of Common Stock
-1.730.5830.8427.8466.7
Upgrade
Repurchase of Common Stock
--3.73-1.01-0.47-0.53-0.06
Upgrade
Other Financing Activities
--11.83-1.19-5.61-0.05-10.32
Upgrade
Financing Cash Flow
-36.17-1.61127.4727.25126.06
Upgrade
Foreign Exchange Rate Adjustments
-----0-0.02
Upgrade
Net Cash Flow
-4.07-54.6459.0429.6718.08
Upgrade
Free Cash Flow
--37.85-49.29-103.42-96.62-80.94
Upgrade
Free Cash Flow Margin
--18.64%-30.07%-93.80%-194.84%-396.06%
Upgrade
Free Cash Flow Per Share
--0.26-0.36-0.76-1.22-1.90
Upgrade
Cash Interest Paid
-26.9527.6910.867.294.56
Upgrade
Levered Free Cash Flow
--27.81-19.62-65.85-28.19-52.91
Upgrade
Unlevered Free Cash Flow
--11.76-5.2-58.6-24.67-47.22
Upgrade
Change in Net Working Capital
14.6924.67-0.731.69-29.095.62
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q